drugset / Trial / NCT00419224

Influenza Vaccination in Bone Marrow Transplantation

NCT00419224 ↗

Phase 4 Completed 36 enrolled The Cleveland Clinic
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether influenza vaccination protects patients who receive a certain type of bone marrow transplantation.

Timeline

Start
2002-10
Primary completion
—
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject inactivated split-virus influenza vaccine Vaccine — —

Indications